Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: Relevance of nucleated red blood cells

Blood

Volumn 100, Issue 7, 2002, Pages 2662-2664

  Stevens, Cladd E ^a,b,c,d   Gladstone, Jessica ^a,b,c,d   Taylor, Patricia E ^a,b,c,d   Scaradavou, Andromachi ^a,b,c,d   Migliaccio, Anna Rita ^a,b,c,d   Visser, Jan ^a,b,c,d   Ludy Dobrila, N ^a,b,c,d   Carrier, Carmelita ^a,b,c,d   Cabbad, Michael ^a,b,c,d   Wernet, Peter ^a,b,c,d   Kurtzberg, Joanne ^a,b,c,d   Rubinstein, Pablo ^a,b,c,d  

^a NEW YORK BLOOD CENTER   (United States)

^b BROOKLYN HOSPITAL CENTER   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOANALYZER; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL COUNT; CHILD; ERYTHROCYTE; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PLACENTA; PRIORITY JOURNAL; STEM CELL; UMBILICAL CORD BLOOD;

EID: 0036786949     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.7.2662     Document Type: Article

References (22)

1. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 1989;86:3828-3832.
2. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood. 1993;81:1679-1690.
3. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A. 1995;92:10119-10122.
4. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157-166.
5. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 1996;88:795-802.
6. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med. 1997;337:373-381.
7. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577.
8. Rocha V, Wagner JE, Sobocinski KA, Gluckman E. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000;342:1846-1854.
9. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815-1822.
10. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000;96:2717-2722.
11. +bright staining cells in human umbilical cord blood: implications for estimating stem cells by CD34 counts [abstract]. Blood. 2000;96:831a.
12. Fisher LD, van Belle G. Biostatistics: A Methodology for the Health Sciences. New York, NY: John Wiley & Sons; 1993.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
14. Cox DR. Regression models and life tables. J R Stat Soc (B). 1972;34:187-220.
15. Issaragrisil S. Correlation between hematopoietic progenitors and erythroblasts in cord blood. Am J Clin Pathol. 1983;80:865-867.
16. de Haan G, Van Zant G. Intrinsic and extrinsic control of hemapoietic stem cell numbers: mapping of a stem cell gene. J Exp Med. 1997;186:529-536.
17. Storb R, Prentice RL, Thomas ED. Marrow transplantation for treatment of aplastic anemia: an analysis of factors associated with graft rejection. N Engl J Med. 1977;296:61-66.
18. Gordon MY, Blackett NM. Some factors determining the minimum number of cells required for successful clinical engraftment. Bone Marrow Transplant. 1995;15:659-662.
19. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood. 1995;86:3961-3969.
20. Bensinger WI, Longin K, Appelbaum F, et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol. 1994;87:825-831.
21. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood. 1995;86:2842-2848.
22. + cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood. 1996;88:3223-3229.